Viral hijacking of host caspases: An emerging category of pathogen-host interactions

Cell Death and Differentiation

Volumn 24, Issue 8, 2017, Pages 1401-1410

  Connolly, Patrick F ^a   Fearnhead, Howard O ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 10; CASPASE 11; CASPASE 12; CASPASE 13; CASPASE 14; CASPASE 16; CASPASE 17; CASPASE 18; CASPASE 3; CASPASE 4; CASPASE 5; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; INITIATOR CASPASE; INTERLEUKIN 1BETA CONVERTING ENZYME; UNCLASSIFIED DRUG; VIRAL PROTEIN;

ADENOVIRIDAE; ALEUTIAN MINK DISEASE VIRUS; APOPTOSIS; ASTROVIRIDAE; AVIAN ORTHOREOVIRUS; CELL DIFFERENTIATION; CELL MIGRATION; CLASSICAL SWINE FEVER VIRUS; HEPATITIS C VIRUS; HOST CELL; HOST PATHOGEN INTERACTION; INFLUENZA A; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; REVIEW; VIRUS PATHOGENESIS; VIRUS RELEASE; VIRUS REPLICATION; WART VIRUS; ANIMAL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; VIROLOGY; VIRUS; VIRUS INFECTION;

ANIMALS; APOPTOSIS; CASPASES; GENE EXPRESSION REGULATION; HOST-PATHOGEN INTERACTIONS; HUMANS; PROTEIN BIOSYNTHESIS; PROTEOLYSIS; SIGNAL TRANSDUCTION; VIRAL PROTEINS; VIRUS DISEASES; VIRUS REPLICATION; VIRUSES;

EID: 85019895958     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2017.59     Document Type: Review

References (120)

1. Earnshaw WC, Martins LM, Kaufmann SH. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 1999; 68: 383-424.
2. Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell 2004; 117: 561-574.
3. Rudel T, Bokoch GM. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science 1997; 276: 1571-1574.
4. Lee KK, Ohyama T, Yajima N, Tsubuki S, Yonehara S. MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J Biol Chem 2001; 276: 19276-19285.
5. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S. A caspase-Activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43-50.
6. Zhou BB, Li H, Yuan J, Kirschner MW. Caspase-dependent activation of cyclin-dependent kinases during Fas-induced apoptosis in Jurkat cells. PNAS 1998; 95: 6785-6790.
7. Galluzzi L, Brenner C, Morselli E, Touat Z, Kroemer G. Viral control of mitochondrial apoptosis. PLoS Pathog 2008; 4: e1000018.
8. Chiou SK, White E. Inhibition of ICE-like proteases inhibits apoptosis and increases virus production during adenovirus infection. Virology 1998; 244: 108-118.
9. Henderson S, Huen D, Rowe M, Dawson C, Johnson G, Rickinson A. Epstein-Barr viruscoded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. PNAS 1993; 90: 8479-8483.
10. Nava VE, Cheng EH, Veliuona M, Zou S, Clem RJ, Mayer ML et al. Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. J Virol 1997; 71: 4118-4122.
11. Cheng EH, Nicholas J, Bellows DS, Hayward GS, Guo HG, Reitz MS et al. A Bcl-2 homolog encoded by Kaposi sarcoma-Associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. PNAS 1997; 94: 690-694.
12. Sarid R, Sato T, Bohenzky RA, Russo JJ, Chang Y. Kaposi's sarcoma-Associated herpesvirus encodes a functional bcl-2 homologue. Nat Med 1997; 3: 293-298.
13. Marshall WL, Yim C, Gustafson E, Graf T, Sage DR, Hanify K et al. Epstein-Barr virus encodes a novel homolog of the bcl-2 oncogene that inhibits apoptosis and associates with Bax and Bak. J Virol 1999; 73: 5181-5185.
14. Nash P, Barrett J, Cao JX, Hota-Mitchell S, Lalani AS, Everett H et al. Immunomodulation by viruses: the myxoma virus story. Immunol Rev 1999; 168: 103-120.
15. Bertin J, Armstrong RC, Ottilie S, Martin DA,Wang Y, Banks S et al. Death effector domaincontaining herpesvirus and poxvirus proteins inhibit both Fas-And TNFR1-induced apoptosis. PNAS 1997; 94: 1172-1176.
16. Hu S, Vincenz C, Buller M, Dixit VM. A novel family of viral death effector domain-containing molecules that inhibit both CD-95-And tumor necrosis factor receptor-1-induced apoptosis. J. Biol Chem 1997; 272: 9621-9624.
17. Best SM, Bloom ME. Caspase activation during virus infection: more than just the kiss of death? Virology 2004; 320: 191-194.
18. Wall DM, McCormick BA. Bacterial secreted effectors and caspase-3 interactions. Cell Microbiol 2014; 16: 1746-1756.
19. Bloom M, Race R, Wolfinbarger J. Characterization of Aleutian disease virus as a parvovirus. J Virol 1980; 35: 836-843.
20. Qiu J, Cheng F, Burger LR, Pintel D. The transcription profile of Aleutian mink disease virus in CRFK cells is generated by alternative processing of pre-mRNAs produced from a single promoter. J Virol 2006; 80: 654-662.
21. Li L, Pesavento PA, Woods L, Clifford DL, Luff J, Wang C et al. Novel amdovirus in gray foxes. Emerg Infect Dis 2011; 17: 1876-1878.
22. Alexandersen S, Bloom ME, Wolfinbarger J. Evidence of restricted viral replication in adult mink infected with Aleutian disease of mink parvovirus. J Virol 1988; 62: 1495-1507.
23. Shimomura S, Wong S, Brown KE, Komatsu N, Kajigaya S, Young NS. Early and late gene expression in UT-7 cells infected with B19 parvovirus. Virology 1993; 194: 149-156.
24. Luo Y, Qiu J. Parvovirus infection-induced DNA damage response. Future Virol 2013; 8: 245-257.
25. Best SM, Wolfinbarger JB, Bloom ME. Caspase activation is required for permissive replication of Aleutian mink disease parvovirus in vitro. Virology 2002; 292: 224-234.
26. Best SM, Shelton JF, Pompey JM, Wolfinbarger JB, Bloom ME. Caspase cleavage of the nonstructural protein NS1 mediates replication of Aleutian mink disease parvovirus. J Virol 2003; 77: 5305-5312.
27. Kuiken T, Taubenberger JK. Pathology of human influenza revisited. Vaccine 2008; 26: 59-66.
28. Bouvier NM, Palese P. The biology of influenza viruses. Vaccine 2008; 26: 49-53.
29. Wurzer WJ, Planz O, Ehrhardt C, Giner M, Silberzahn T, Pleschka S et al. Caspase 3 activation is essential for efficient influenza virus propagation. EMBO J 2003; 22: 2717-2728.
30. Zhirnov OP, Konakova TE, Garten W, Klenk H. Caspase-dependent N-terminal cleavage of influenza virus nucleocapsid protein in infected cells. J Virol 1999; 73: 10158-10163.
31. Zhirnov OP, Syrtzev VV. Influenza virus pathogenicity is determined by caspase cleavage motifs located in the viral proteins. J Mol Genet Med 2009; 3: 124-132.
32. Olsen CW, Kehren JC, Dybdahl-Sissoko NR, Hinshaw VS. Bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation. J Virol 1996; 70: 663-666.
33. McLean JE, Datan E, Matassov D, Zakeri ZF. Lack of Bax prevents influenza A virus-induced apoptosis and causes diminished viral replication. J Virol 2009; 83: 8233-8246.
34. Mebratu YA, Tipper J, Chand HS, Walton S, Harrod KS, Tesfaigzi Y. Bik mediates caspasedependent cleavage of viral proteins to promote influenza A virus infection. Am J Respir Cell Mol Biol. 2016; 54: 664-673.
35. Zhirnov OP, Vorobjeva IV, Veselovski EM, Klenk HD. Key role of Asp16 in the cleavage of influenza A virus NP protein in infected cells. Probl Virol 2003; 48: 8-14.
36. Ozawa M, Fujii K, Muramoto Y, Yamada S, Yamayoshi S, Takada A et al. Contributions of two nuclear localization signals of influenza A virus nucleoprotein to viral replication. J Virol 2007; 81: 30-41.
37. Lipatov AS, Yen HL, Salomon R, Ozaki H, Hoffmann E, Webster RG. The role of the N-terminal caspase cleavage site in the nucleoprotein of influenza A virus in vitro and in vivo. Arch Virol 2008; 153: 427-434.
38. Zhirnov OP, Bukrinskaya AG. Two forms of influenza virus nucleoprotein in infected cells and virions. Virology 1981; 109: 174-179.
39. Kiyosawa K, Sodeyama T, Tanaka E, Gibo Y, Yoshizawa K, Nakano Y et al. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-675.
40. Reed KE, Rice CM. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr Top Microbiol Immunol 2000; 242: 55-84.
41. El-Hage N, Luo G. Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA. J Gen Virol 2003; 84: 2761-2769.
42. Lindenbach BD, Rice CM. The ins and outs of hepatitis C virus entry and assembly. Nat Rev Microbiol 2013; 11: 688-700.
43. Honda M, Kaneko S, Shimazaki T, Matsushita E, Kobayashi K, Ping LH et al. Hepatitis C virus core protein induces apoptosis and impairs cell-cycle regulation in stably transformed Chinese hamster ovary cells. Hepatology 2000; 31: 1351-1359.
44. Benali-Furet NL, Chami M, Houel L, De Giorgi F, Vernejoul F, Lagorce D et al. Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion. Oncogene 2005; 24: 4921-4933.
45. Satoh S, Hirota M, Noguchi T, Hijikata M. Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease in mammalian cells. Virology 2000; 487: 476-487.
46. Hidajat R, Nagano-Fujii M, Deng L, Hotta H. Cleavage of the hepatitis C virus NS5A protein by caspase-3 in the interferon sensitivity-determining region in a sequencedependent manner. Kobe J Med Sci 2004; 50: 153-166.
47. Maqbool MA, Imache MR, Higgs MR, Carmouse S, Pawlotsky JM, Lerat H. Regulation of hepatitis C virus replication by nuclear translocation of nonstructural 5A protein and transcriptional activation of host genes. J Virol 2013; 87: 5523-5539.
48. Ghosh AK, Steele R, Meyer K, Ray R, Ray RB. Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J Gen Virol 1999; 80: 1179-1183.
49. Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC et al. HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis. Oncogene 2002; 21: 4801-4811.
50. Chung YL, Sheu ML, Yen SH. Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma. Int J Cancer 2003; 107: 65-73.
51. Li Y, Zhang Q, Liu Y, Luo Z, Kang L, Qu J et al. Hepatitis C virus activates Bcl-2 and MMP-2 expression through multiple cellular signaling pathways. J Virol 2012; 86: 12531-12543.
52. American Cancer Society. Cancer Facts & Figures 2014. American Cancer Society; 2014. Accessed: Atlanta, 2016.
53. Lowy DR, Schiller JT. Reducing HPV-Associated cancer globally. Cancer Prev Res 2012; 5: 18-23.
54. Zheng ZM, Baker CC. Papillomavirus genome structure, expression, and posttranscriptional regulation. Front Biosci 2006; 11: 2286-2302.
55. Graham S. Human papillomavirus: gene expression, regulation and prospects for novel diagnostic methods and antiviral therapies. Future Microbiol 2010; 5: 1493-1506.
56. Schiller JT, Day PM, Kines RC. Current understanding of the mechanism of HPV infection. Gynecol Oncol 2010; 118: S12.
57. Doorbar J. The papillomavirus life cycle. J Clin Virol 2005; 32: S7-15.
58. Moody CA, Fradet-Turcotte A, Archambault J, Laimins LA. Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. PNAS 2007; 104: 19541-19546.
59. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990; 63: 1129-1136.
60. Filippova M, Parkhurst L, Duerksen-Hughes PJ. The human papillomavirus 16 E6 protein binds to Fas-Associated death domain and protects cells from Fas-triggered apoptosis. J Biol Chem 2004; 279: 25729-25744.
61. Garnett TO, Filippova M, Duerksen-Hughes PJ. Accelerated degradation of FADD and procaspase 8 in cells expressing human papilloma virus 16 E6 impairs TRAIL-mediated apoptosis. Cell Death Differ 2006; 13: 1915-1926.
62. Ascher JM, Geneva AJ, Ng J, Wyatt JD, Glor RE. Phylogenetic analyses of novel squamate adenovirus sequences in wild-caught Anolis lizards. PloS One 2013; 8: e60977.
63. Ghebremedhin B. Human adenovirus: Viral pathogen with increasing importance. Eur J Microbiol Immunol 2014; 4: 26-33.
64. Russell WC. Adenoviruses: update on structure and function. J Gen Virol 2009; 90: 1-20.
65. Meier O, Greber UF. Adenovirus endocytosis. J Gene Med 2003; 5: 451-462.
66. Grand R, Schmeiser K, Gordon E. Caspase-mediated cleavage of adenovirus early region 1A proteins. Virology 2002; 271: 255-271.
67. Berk AJ. Recent lessons in gene expression, cell cycle control, and cell biology from adenovirus. Oncogene 2005; 24: 7673-7685.
68. Madeley CR. 28 nm particles in faeces in infantile gastroenteritis. Lancet 1975; 7932: 451-452.
69. Kapoor A, Li L, Victoria J, Oderinde B, Mason C, Pandey P et al. Multiple novel astrovirus species in human stool. J Gen Virol 2009; 90: 2965-2972.
70. Guix S, Bosch A, Pintó RM. Human astrovirus diagnosis and typing: current and future prospects. Lett Appl Microbiol 2005; 41: 103-105.
71. Méndez E, Aguirre-Crespo G. Association of the astrovirus structural protein VP90 with membranes plays a role in virus morphogenesis. J Virol 2007; 81: 10649-10658.
72. Méndez E, Muñoz-Yañez C, Sánchez-San Martín C, Aguirre-Crespo G, Baños-Lara Mdel R, Gutierrez M et al. Characterization of human astrovirus cell entry. J Virol 2014; 88: 2452-2460.
73. Dong J, Dong L, Méndez E, Tao Y. Crystal structure of the human astrovirus capsid spike. PNAS 2011; 108: 12681-12686.
74. Banos-Lara MDR, Méndez E. Role of individual caspases induced by astrovirus on the processing of its structural protein and its release from the cell through a non-lytic mechanism. Virology 2010; 401: 322-332.
75. Méndez E, Salas-Ocampo E, Arias CF. Caspases mediate processing of the capsid precursor and cell release of human astroviruses. J Virol 2004; 78: 8601-8608.
76. Engström BE. Blue wing disease of chickens: isolation of avian reovirus and chicken anaemia agent. Avian Pathol 1988; 17: 23-32.
77. Engström BE, Luthman M. Blue wing disease of chickens: signs, pathology and natural transmission. Avian Pathol 1984; 13: 1-12.
78. Teng L, Xie Z, Xie L, Liu J, Pang Y, Deng X et al. Complete genome sequences of an avian orthoreovirus isolated from Guangxi, China. Genome Announc 2013; 1: e00495-13.
79. Broering TJ, Kim J, Miller CL, Piggott CD, Dinoso JB, Nibert ML et al. Reovirus nonstructural protein mu NS recruits viral core surface proteins and entering core particles to factory-like inclusions. J Virol 2004; 78: 1882-1892.
80. Rodríguez-Grille J, Busch LK, Martínez-Costas J, Benavente J. Avian reovirus-triggered apoptosis enhances both virus spread and the processing of the viral nonstructural muNS protein. Virology 2014; 462-463: 49-59.
81. Tourís-Otero F, Cortez-San Martín M, Martínez-Costas J, Benavente J. Avian reovirus morphogenesis occurs within viral factories and begins with the selective recruitment of ?NS and ?A to ?NS inclusions. J Mol Biol 2004; 341: 361-374.
82. Broering TJ, Arnold MM, Miller CL, Hurt JA, Joyce PL, Nibert ML. Carboxyl-proximal regions of reovirus nonstructural protein muNS necessary and sufficient for forming factorylike inclusions. J Virol 2005; 79: 6194-6206.
83. Center for Food Security & Public Health. Classical Swine Fever. Factsheet. 2015; Ames, Iowa. Available at http://www.cfsph.iastate.edu/Factsheets/pdfs/classical-swine-fever.pdf. Accessed 6 Dec 2016.
84. Xie J, Guo H, Gong W, Jiang D, Zhang L, Jia J et al. Identification of cleavage of NS5A of C-strain classical swine fever virus. Arch Virol 2016; 162: 391-400.
85. Slee EA, Adrain C, Martin SJ. Executioner caspase-3,-6, and-7 perform distinct, nonredundant roles during the demolition phase of apoptosis2001 J Biol Chem 276: 7320-7326.
86. Zhang C, Kang K, Ning P, Peng Y, Lin Z, Cui H et al. Heat shock protein 70 is associated with CSFV NS5A protein and enhances viral RNA replication. Virology 2015; 482: 9-18.
87. Cohen S, Marr AK, Garcin P, Panté N. Nuclear envelope disruption involving host caspases plays a role in the parvovirus replication cycle. J Virol 2011; 85: 4863-4874.
88. Mühlbauer D, Dzieciolowski J, Hardt M, Hocke A, Schierhorn KL, Mostafa A et al. Influenza virus-induced caspase-dependent enlargement of nuclear pores promotes nuclear export of viral ribonucleoprotein complexes. J Virol 2015; 89: 6009-6021.
89. Butin-Israeli V, Drayman N, Oppenheim A. Simian virus 40 infection triggers a balanced network that includes apoptotic, survival, and stress pathways. J Virol 2010; 84: 3431-3442.
90. Butin-Israeli V, Ben-nun-Shaul O, Kopatz I, Adam SA, Shimi T, Goldman RD et al. Simian virus 40 induces lamin A/C fluctuations and nuclear envelope deformation during cell entry. Nucleus 2011; 2: 320-330.
91. Bideshi DK, Tan Y, Bigot Y, Federici BA. A viral caspase contributes to modified apoptosis for virus transmission. Genes Dev 2005; 19: 1416-1421.
92. Bideshi DK, Demattei MV, Rouleux-Bonnin F, Stasiak K, Tan Y. Genomic sequence of Spodoptera frugiperda Ascovirus 1a, an enveloped, double-stranded DNA insect virus that manipulates apoptosis for viral reproduction. J Virol 2006; 80: 11791-11805.
93. Asgari S. A caspase-like gene from Heliothis virescens ascovirus (HvAV-3e) is not involved in apoptosis but is essential for virus replication. Virus Res 2007; 128: 99-105.
94. Hussain M, Garrad S, Asgari S. The role of actin filaments in ascovirus replication and pathology. Arch Virol 2009; 154: 1737-1743.
95. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F et al. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997; 386: 517-521.
96. Ennaciri J, Menezes J, Proulx F, Toledano BJ. Induction of apoptosis by herpes simplex virus-1 in neonatal, but not adult, neutrophils. Pediatr Res 2005; 59: 7-12.
97. Karlberg H, Tan YJ, Mirazimi A. Induction of caspase activation and cleavage of the viral nucleocapsid protein in different cell types during Crimean-Congo hemorrhagic fever virus infection. J Biol Chem 2011; 286: 3227-3234.
98. Arslan SY, Son KN, Lipton HL. During infection, Theiler's virions are cleaved by caspases and disassembled into pentamers. J Virol 2016; 90: 3573-3583.
99. Wolff S, Becker S, Groseth A. Cleavage of the Junin virus nucleoprotein serves a decoy function to inhibit the induction of apoptosis during infection. J Virol 2013; 87: 224-233.
100. Connolly PF, Jäger R, Fearnhead HO. New roles for old enzymes: killer caspases as the engine of cell behavior changes. Front Physiol 2014; 5: 149.
101. Pan T, Wu S, He X, Luo H, Zhang Y, Fan M et al. Necroptosis takes place in human immunodeficiency virus type-1 (HIV-1)-infected CD4+ T lymphocytes. PLoS One 2014; 9: e93944.
102. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri E, Baehrecke E et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2008; 16: 3-11.
103. Overholtzer M, Mailleux AA, Mouneimne G, Normand G, Schnitt SJ, King RW et al. A non-Apoptotic cell death process, entosis, that occurs by cell-in-cell invasion. Cell 2007; 131: 966-979.
104. Zhang Y, Li Z, Ge X, Guo X, Yang H. Autophagy promotes the replication of encephalomyocarditis virus in host cells. Autophagy 2011; 7: 613-628.
105. Faucheu C, Diu A, Chan AW, Blanchet AM, Miossec C, Hervé F et al. A novel human protease similar to the interleukin-1 beta converting enzyme induces apoptosis in transfected cells. EMBO J 1995; 14: 1914-1922.
106. Munday NA, Vaillancourt JP, Ali A, Casano FJ, Miller DK. Molecular cloning and pro-Apoptotic activity of ICErelII and ICErelIII, members of the ICE/CED-3 family of cysteine proteases. J Biol Chem 1995; 270: 15870-15876.
107. Igarashi Y, Eroshkin A, Gramatikova S, Gramatikoff K, Zhang Y, Smith JW et al. CutDB: a proteolytic event database. Nucleic Acids Res. 2007; 35: D546-D549.
108. Wang S, Miura M, Jung YK, Zhu H, Li E, Yuan J. Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE. Cell 1998; 92: 501-509.
109. Van de Craen M, Vandenabeele P, Declercq W, Van den Brande I, Van Loo G, Molemans F et al. Characterization of seven murine caspase family members. FEBS Lett 1997; 403: 61-69.
110. Humke EW, Ni J, Dixit VM. ERICE, a novel FLICE-Activatable caspase. J Biol Chem 1998; 273: 15702-15707.
111. Wang L, Miura M, Bergeron L, Zhu H, Yuan J. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death. Cell 1994; 78: 739-750.
112. Boldin MP, Varfolomeev EE, Pancer Z, Mett IL, Camonis JH,Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem 1995; 270: 7795-7798.
113. Duan H, Orth K, Chinnaiyan AM, Poirier GG, Froelich CJ, He WW et al. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B. J Biol Chem 1996; 271: 16720-16724.
114. Fernandes-Alnemri T, Armstrong RC, Krebs J, Srinivasula SM, Wang L, Bullrich F et al. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. PNAS 1996; 93: 7464-7469.
115. Eckhart L, Ballaun C, Uthman A, Kittel C, Stichenwirth M, Buchberger M et al. Identification and characterization of a novel mammalian caspase with proapoptotic activity. J Biol Chem 2005; 280: 35077-35080.
116. Fernandes-Alnemri T, Litwack G, Alnemri ES. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 1994; 269: 30761-30764.
117. Fernandes-Alnemri T, Litwack G, Alnemri ES. Mch2, a new member of the apoptotic Ced-3/Ice cysteine protease gene family. Cancer Res 1995; 55: 2737-2742.
118. Fernandes-Alnemri T, Takahashi A, Armstrong R, Krebs J, Fritz L, Tomaselli KJ et al. Mch3, a novel human apoptotic cysteine protease highly related to CPP32. Cancer Res 1995; 55: 6045-6052.
119. Hu S, Snipas SJ, Vincenz C, Salvesen G, Dixit VM. Caspase-14 is a novel developmentally regulated protease. J Biol Chem 1998; 273: 29648-29653.
120. Eckhart L, Ballaun C, Hermann M, VandeBerg JL, Sipos W, Uthman A et al. Identification of novel mammalian caspases reveals an important role of gene loss in shaping the human caspase repertoire. Mol Biol Evol 2008; 25: 831-841.